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DISSERTATION ABSTRACT 
South Africa is faced with one of the worst dual epidemics of tuberculosis (TB) and HIV 
worldwide. Gender is intrinsically linked to the way individuals experience health outcomes. 
Globally, there are significant gender differences in the clinical characteristics of TB cases as 
well as in the occurrence of TB disease. Studies have identified a range of factors potentially 
contributing to these differences. However, despite the strong association between HIV and 
TB as well as the well-established fact that females are more susceptible to HIV infection 
than males, few studies in HIV-burdened settings such as South Africa have explored 
gender differences in TB, let alone investigated the effect of HIV on gender differences. We 
hypothesized that the increased burden of TB disease among young females in Cape Town 
is primarily due to HIV infection in this age group. 
During 2009, City of Cape Town TB clinics prospectively collected routine notification data
on 29,478 new TB cases. The objectives of this analysis were to describe the 2009 Cape
Town TB case population by gender, age, and HIV; explore associations between gender,
clinical characteristics, and HIV in TB cases; and estimate age-specific TB notification rates
by gender and HIV.
The protocol (Part A) describes the research methodology and statistical analysis used in 
this study. The literature summary (Part B) describes the burden of HIV and TB; differences
in the burden of TB by age and gender; differences in the clinical characteristics of male and
female TB cases; and factors potentially affecting these gender differences. Lastly, this
summary identifies gaps in the literature, which the following study aims to address.
The journal ready article (Part C) presents the results of this study and discussion on key
findings. To our knowledge this is the first study to investigate the effect of HIV on gender
differences in TB in South Africa. The crude female:male ratio among cases was 0.83.
Among 15-54 year old adult cases, females were significantly younger than males and less 
likely than males to have pulmonary TB, have smear results recorded, be smear-positive, or
have advanced smear-positivity grading. Females were more likely than males to be HIV-
positive. HIV co-infection widened pre-existing clinical differences between male and female
cases. Among HIV-negative adults, age-specific male notification rates exceeded female
rates at all ages to a 2.5-fold difference among 45-49 year olds. The rate in 15-19 year old 
HIV-positive females was 12.4% higher than in males of that age, after which male rates
increasingly exceeded female rates to a 2-fold difference among 45-49 year olds. The
disparity between male and female rates was smaller among HIV-positive than HIV-negative
individuals.
This is the first study to conduct an in-depth analysis of the effect of HIV on TB-related 
gender differences in South Africa. The age and gender pattern of TB disease in the HIV-
positive population has only been reported in Malawi, Uganda, and mid-20th century 
countries. The HIV-negative pattern mirrors gender differences in all other countries 
reporting disaggregated data. HIV co-infection is associated with an increased risk of TB 
disease, particularly among young females, and has led to decreased gender differences. 
Controlling for HIV did not nullify gender differences, which indicates that there are additional 
contributing factors. This study warrants improved HIV and TB testing and treatment 
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1.1.1 TB and HIV in South Africa 
 
South Africa, a country of approximately 50.6 million people [1], reported nearly 400,000 
total tuberculosis (TB) cases in 2011 [2]. This estimate accounts for one-quarter of the 
burden of TB disease in sub-Saharan Africa [3, 4]. In addition, South Africa carries the 
largest burden of Human Immunodeficiency Virus (HIV) in the world, contributing 5.6 million 
HIV positive individuals to the global burden of 34 million [5]. South Africa's efforts to reduce 
the burden of TB has been hindered by insufficient TB cure rates and TB case detection 
rates, a generalised HIV epidemic, and deep-rooted social issues such as poverty and poor 
living conditions [2, 3, 6–10]. 
 
Dubbed the “cursed duet”, HIV and TB have a synergistic relationship whereby people living 
with HIV experience a significantly increased risk of developing TB disease compared to 
those not living with HIV [11]. Wood et al. [6] reported 29,478 incident TB cases in 2009, of 
which 51.4% of those who tested were HIV positive. In this population, there was a 17-fold 
increased risk of developing TB disease among HIV positive individuals compared to HIV 
negative individuals [6]. In the HIV negative population, the highest number of TB cases was 
among 20-24 year olds, and in the HIV positive population, the highest number of TB cases 
was among 30-34 year olds [6]. 
 
1.1.2 Gender differences in TB disease 
 
Differences in male and female TB notification rates have been observed throughout history. 
During the 1930s to 1950s in industrialised countries such as England and Wales, there was 
a very high burden of TB disease which varied by age and gender. TB notification rates in 
children were similar among males and females, after which the notification rates in young 
adults were higher among females than males and the notification rates in older adults were 
higher among males than n females [12]. As a result of effective TB control programs, TB 
notification rates decreased substantially by 1970 and the distribution of TB disease among 
males and females changed. While TB notification rates among male and female children 
still remained equal, male notification rates increasingly exceeded female notification rates 
from adolescence through adulthood, and the excess rates previously seen among young 
females diminished [12]. Figure 1, taken directly from Holmes et al.'s [12] paper, illustrates 
the shift in age-specific male and female tuberculosis notification rates in England and Wales 
in 1952 and 1970. 
 
The burden of TB disease (absolute TB case numbers and TB notification rates) in low- and 
middle-income countries today is similar in magnitude to what was experienced in 
industrialised countries during the mid-20th century [12, 13]. However, two different age and 
gender patterns of TB cases and notification rates have been identified in current literature. 
The majority of literature published in low- and middle-income countries today report an age 
and gender pattern of TB disease similar to that of 1970 in industrialized countries [12, 14–
16]. However, Malawi, Uganda, and South Africa reported a TB disease burden similar to the 
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Figure 1 - Shift in tuberculosis notification rates in England and Wales, 1952 and 1970 [12] 
Under notification, sex-specific mechanisms, and epidemiological differences are frequently
cited as factors associated with the disproportionate burden of TB disease among males
after childhood in many low- and middle-income countries. Under notification of females is
commonly associated with barriers that decrease access to care for females such as lack of
access to finances, legal rights, and education [12], lower social status [12], lower
prioritization of health [19], feelings of embarrassment or shame [20], and TB clinics being
inaccessible by foot [21]. In addition, findings show that certain genetic polymorphisms
increase males’ susceptibility to TB [22]. Mice studies also found that testosterone treatment
increased susceptibility to M.marinum and M.intracellulare [23, 24] while oestrogen
treatment reduced susceptibility to M.avium [25]. Lastly, males engage in higher levels of 
social interactions than females in some settings, thereby increasing their risk of TB
exposure and subsequent development of TB disease [26, 27]. All of these factors may
explain why adolescent and adult males have a higher burden of TB disease than females in
the majority of low- and middle-income countries who reported gender differences related to
TB disease. 
However, in Malawi, Uganda, and South Africa, there were high prevalences of HIV during 
the time these data were collected [18, 28, 29], which may largely explain why females had 
an increased susceptibility to TB in these settings. This supposition is substantiated by 
findings of increased numbers of TB cases in populations with high prevalences of HIV 
infection; increased prevalences of HIV among TB cases; and a higher risk of developing TB 
disease in immune suppressed individuals [18]. Furthermore, Lawn et al. [18] and Crampin 
et al. [17] identified HIV as a major factor shifting the age and gender distribution of TB 
disease in their populations, particularly among young females. Therefore, it is likely that HIV 
and its underlying immunological and socio-behavioural pathways is a major contributor to 
the unique age and gender pattern of TB disease observed in these three settings. In 
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rather than males engage in higher levels of social mixing, which may also be influencing 
females' risk of TB in South Africa [30]. 
 
Further to gender differences in the risk of TB disease, there are also differences in the 
clinical characteristics of male and female TB cases. Research shows that females are less 
likely than males to be asked by healthcare providers to submit sputum for analysis [31–33]. 
Authors suggested that this is a result of provider bias, whereby providers are less likely to 
suspect females of having TB and therefore less likely to acquire sputum samples from them 
[33]. In addition, another study suggested that females are less able to produce sputum than 
males [34], which may be biological or a socio-cultural barrier related to social norms and not 
feeling comfortable expectorating sputum in public [35].  
 
Of the females that submit sputum for analysis, studies mainly found that females were less 
likely than males to be smear positive [31–33]. This could again be due to females producing 
poor quality sputum that is in fact saliva rather than sputum, which could lead to false 
negative results [31]. In addition, it is well established that HIV-related immune suppression 
leads to disseminated TB and fewer bacilli present in sputum [36, 37], which reduces the 
likelihood of smear positivity. This is particularly relevant in HIV-burdened Malawi, Uganda, 
and South Africa.  
 
1.2 Dissertation rationale 
 
Although gender is intrinsically linked to health outcomes, the most recent review on gender 
and TB epidemiology was published by Holmes et al. [12] in 1998. Since then, a number of 
studies have been published but many have discussed the need for further research on this 
topic to fill the gaps and draw clearer conclusions. Furthermore, despite the strong 
association between TB and HIV, few studies conducted in HIV-burdened countries have 
explored the effect that HIV may be having on gender differences related to TB disease. My 
hypothesis is that the increased burden of TB disease among young females in Cape Town 
is primarily due to HIV infection among this age group.  
 
The need for further research is particularly relevant for South Africa, which is struggling to 
curb the dual epidemic of HIV and TB. Yet, in this setting, only one study by Austin et al. [33] 
has been published and it did not analyze the impact of HIV on observed gender differences. 
In addition, 2009 was the first year that TB clinics in Cape Town began recording HIV-related 
information in the electronic TB register. High HIV testing rates and the availability of these 
data will enable a rigorous analysis of gender differences in TB disease as well as HIV's 
affect on these differences in Cape Town. This analysis aims to enhance knowledge about 
gender, TB disease, and HIV in Cape Town as well as provide evidence to support a multi-
pronged approach to TB control that considers age, gender, and HIV. 
 
1.3 Research questions 
 
1. What are the demographic and clinical differences between male and female Cape 
Town TB cases? 
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3. How does HIV affect differences in the clinical characteristics and TB notification
rates between males and females in Cape Town (Figure 2)?
Figure 2 - Effect modification 
1.4 Dissertation objectives 
1. To describe the 2009 Cape Town TB case population by gender, age, and HIV and 
determine corresponding standardized female:male ratios;
2. to explore associations between gender and clinical characteristics of TB cases and
the impact of HIV on these associations;
3. to estimate age-specific TB notification rates by gender and HIV and determine
corresponding notification rate ratios; and
4. to draw conclusions regarding the impact of HIV on observed gender differences.
2.0 METHODS 
2.1 Study design 
These routine data were prospectively collected from City of Cape Town public TB clinics 
from 1 January to 31 Decemb r, 2009. TB clinics are governed by City of Cape Town local 
authorities and provide free TB services to residents. All patient information is consecutively 
recorded in standardised paper TB registers at each health facility and then collated into a 
centralised electronic TB database as per the guidelines of the South African National TB 
Control Program [40]. 
The primary analysis of these data was published in 2011 by Wood et al. [6] entitled “Burden 
of New and Recurrent TB in a Major South African City Stratified by Age and HIV-Status”. 




















Figure 3 - 2009 mid-year Cape Town population structure [6] 
 
Cape Town, South Africa is an urban city located in the Western Cape province and has a 
population of approximately 3,443,010 people [6, 41]. The population pyramid in Figure 3 
describes this population by age and gender [6]. Males and females appear to have similar 
age distributions with the largest proportion of the population being 20-29 years old. The 




2.3.1 Inclusion criteria 
 
 All new TB cases commencing TB treatment at City of Cape Town TB clinics 
from 1 January to 31 December, 2009. 
 
2.3.2 Exclusion criteria 
 
 Cases who were not enrolled at City of Cape Town TB clinics for TB treatment. 
 Cases who commenced TB treatment before 1 January, 2009 or after 31 
December, 2009. 
 Cases who were receiving TB treatment at a clinic outside of the metropolitan 
area and subsequently transferred to a City of Cape Town TB clinic during 
treatment. 
 Cases who were receiving TB treatment at a clinic inside of the metropolitan area 
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2.3.3 Sample size 
The original dataset included the entire Cape Town TB case population, which consisted of 
31,093 cases. However, as a result of the exclusions specified above, the primary analysis 
included 29,478 cases. Therefore, the proposed analysis will also use the same exclusion 
criteria and include 29,478 cases. 
2.4 Measurement 
2.4.1 Instruments 
These data were acquired from the Cape Town electronic TB register. 
2.4.2 Variables 
Variable Type Options
Gender Binary Male, female
Case number Nominal 1-29,478
Age Continuous 0-105 years
Age Ordinal 0-75 years across 5-year age strata
Disease classification Nominal Pulmonary, extra-pulmonary, both 
HIV status Nominal Positive, negative, unknown 
Baseline sputum submitted Nominal Yes, no, no data 
Baseline smear microscopy results Nominal Negative, positive, not done 
Baseline smear positivity grading Ordinal Scanty, +, ++, +++, (no data) 
2.4.3 Definitions 
 Sputum smear-positive: Individuals who have had a positive sputum smear result on
one or more occasions.
 HIV positive: Individuals were considered HIV positive if they were recorded as HIV
positive in the TB register OR met any of the following criteria based on their TB
register data: had a CD4 count recorded, were on antiretroviral therapy, or had taken
cotrimoxazole prophylaxis.
 HIV negative: Individuals were considered HIV negative if they were recorded as HIV
negative in the TB register and did not meet any of the criteria for being HIV positive.
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2.4.4 Validity and reliability of instruments 
 
Data collection for the TB register is ongoing and the clinic staff receive in-depth training on 
how to correctly capture information. In addition, organisations such as Desmond Tutu HIV 
Centre work closely with the TB register and run consistency checks to minimize data errors. 
Completed pages of the TB register are also regularly sent to the City of Cape Town offices 
for review and data entry. 
 
3.0 ANALYSIS PLAN 
 
3.1 Data management 
 
All data will be managed, carefully cleaned, systematically coded and password protected in 
Microsoft Excel and STATA 11.0 (StataCorp, College Station, Texas). 
 
3.2 Data analysis 
 
 Descriptive statistics will be employed to summarize demographics and clinical 
characteristics of TB cases. 
 A bivariate analysis will be employed to explore differences in clinical characteristics 
between male and female TB cases. 
 Standardized female:male ratios for each age stratum among TB cases will be 
calculated by dividing age-specific female:male ratios among TB cases by the overall 
crude female:male ratio among TB cases. 
 Logistic and multinomial regression modelling will be used to explore associations 
between gender and clinical characteristics of TB cases, while adjusting for potential 
confounders. 
 A sensitivity analysis will be conducted to best approximate the probable HIV status 
of TB cases with indeterminate HIV information. HIV unknown TB cases will be 
apportioned as (A) HIV positive, (B) HIV negative, and (C) as HIV positive or 
negative according to existing HIV rates among TB cases. 
 Cape Town population denominators stratified by age, gender, and HIV will be 
estimated using Western Cape province data acquired from the Actuarial Society of 
South Africa. Using these data, Cape Town TB notification rates per 100,000 by age, 
gender, and HIV as well as corresponding notification rate ratios will be estimated 
using Poisson regression modelling. 
 
4.0 ETHICAL CONSIDERATIONS 
 
4.1 Ethics approval 
 
Wood et al. [6] did not receive ethics approval prior to conducting their analysis, as these 
data were routine notification data and analysed at the population level without identifying 
information.  However, for the purposes of this dissertation, ethics approval from University 
of Cape Town's Health Research Ethics Committee was obtained on 20 April 2012 (REF# 
187/2012). In addition, approval from City of Cape Town, City Health to use these data for a 
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4.2 Risks and benefits 
 
These data have not been collected specifically for research study purposes but rather 
through routine TB surveillance. There are no risks involved in the analysis of these data. 
However, these findings may provide beneficial gender-specific information for improving TB 
control strategies in the future. 
 
4.3 Informed consent process 
 
These data are routinely collected for all TB cases and will be analysed without identifiers, 
so no informed consent was obtained. 
 
4.4 Privacy and confidentiality 
 
All patient information will be kept strictly confidential and the analysis will be conducted 
without any personal identifying information. 
 
4.5 Reimbursement for participants 
 
These data were not collected as part of a research study and thus no reimbursements were 




 TB/HIV organisations such as Desmond Tutu HIV Centre 
 University of Cape Town 
 Residents of Cape Town 
 Public health officials 
 City of Cape Town clinics 
 Gender-based organisations 
 
5.0 REPORTING AND IMPLEMENTATION 
 
Using these data, I will write my Master of Public Health degree dissertation. I will aim to 
publish one journal article in a peer-reviewed journal and present my findings at a Desmond 
Tutu HIV Foundation research meeting and any conferences upon request. Furthermore, all 





















Table 1 - Timetable for dissertation completion  
Milestone Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan 
Write/edit protocol            
Submit protocol to ethics            
Conduct analysis            
Write/edit journal article            
Write/edit literature review            
Format dissertation            
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1.0 INTRODUCTION AND OBJECTIVES 
 
Males and females are differentially affected by tuberculosis (TB). Studies have identified a 
range of socio-cultural, economic, epidemiological, and biological factors potentially 
contributing to these differences. Despite the strong association between Human 
Immunodeficiency Virus (HIV) and TB as well as the fact that females are more susceptible 
to HIV infection than males, few studies have been conducted in HIV-burdened settings such 
as South Africa to investigate the effect of HIV on observed gender differences.  
 
This dissertation investigates gender differences in the clinical characteristics of TB cases as 
well as in the age-specific occurrence of TB disease in Cape Town. In addition, the effect of 
HIV on these gender differences will also be explored. The hypothesis is that the increased 
burden of TB disease among young females in Cape Town is primarily due to HIV infection 
among this age group. 
 
This literature review was conducted to provide background information to inform the 
dissertation. The objectives were:  
 
 to identify the burden of TB and HIV in the global and South African context; 
 to describe gender differences in the occurrence of TB disease historically and 
currently; 
 to describe gender differences in the clinical characteristics of TB cases; and 
 to ascertain factors, such as HIV, potentially contributing to these gender differences. 
 
2.0 SEARCH STRATEGY 
 
The following search strategies were used for this literature review: 
 
1.1 Search engines 
 
PubMed and Google Scholar were used to search for relevant articles using various 
combinations of the search terms below. Article abstracts were screened for relevance, 
quality, and whether they met the inclusion criteria below. In addition, related references in 
the obtained articles were identified and followed up on.  
 
1.2 Exclusion criteria 
 
 Studies investigating gender differences in TB infection 
 Non-English journal articles 
 Non-published or non-peer reviewed articles 
 
1.3 Inclusion criteria 
 
 Global and South African studies 
 Qualitative and quantitative studies of all study designs 
 Studies exploring gender differences in the clinical characteristics of TB cases 
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 Studies exploring gender differences in crude and age-specific TB notification rates 
 Studies investigating epidemiological, socio-cultural, economic, and biological factors 
associated with gender differences in TB disease    
 
1.4 Search terms 
 
The search terms listed below were used in varying logical combinations to identify relevant 
literature. 
 
 Gender; sex; male; female 
 Gender differences; sex differences; gender inequality 
 Tuberculosis; TB; HIV; HIV/TB co-infection 
 South Africa 
 Biological; socio-cultural; economic 
 Epidemiology; burden; incidence; transmission; seroconversion 
 Social mixing; social interactions 
 Health seeking behaviors 
 
3.0 REVIEW OF LITERATURE 
 
1.5 TB transmission  
 
TB is an airborne infectious disease caused by the bacterium Mycobacterium Tuberculosis 
(M.tuberculosis), that has plagued humans from all walks of life since 1000 B.C. [1, 2]. It 
primarily affects the lungs but also disseminates to other organ systems as well, particularly 
among immune suppressed individuals [1, 3]. Through the act of sneezing, coughing, or 
even talking, infectious individuals release M.tuberculosis particles from their lungs, which 
form stable droplet nuclei that remain suspended in the air for long periods of time [4]. Even 
in a single sneeze, there are more than one million M.tuberculosis particles [4]. Susceptible 
individuals acquire TB infection through the inhalation of infected respiratory droplet nuclei 
[4]. Overcrowding, poor living conditions and poor ventilation are conducive environments 
associated with an increased risk of developing TB disease [5, 6]. 
 
1.6 The global burden of TB 
 
Approximately 1/3 of the world’s population is infected with latent TB[1]. HIV negative 
individuals with latent TB have a 10% lifetime risk of developing TB disease and individuals 
co-infected with HIV and latent TB have as high as a 30-40% lifetime risk of developing TB 
disease [1, 7]. Although annual global TB incidence rates declined by approximately 2.2% 
from 2010 to 2011, there are still an estimated 8.7 million annual incident TB cases 
worldwide [8]. The male:female ratio among new smear-positive TB notifications was 1.9 [8]. 
More than half (59%) of new cases occurred in Asia, 26% in Africa, and the remaining 15% 
in the Eastern Mediterranean region, the European region, and the Americas [8]. The five 
countries contributing the largest numbers of incident TB cases during 2011 were India, 
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TB is the second leading cause of infectious disease death worldwide after HIV and 
Acquired Immune Deficiency Syndrome (AIDS) [1]. According to research on the natural 
history of TB, approximately 70% of HIV-negative cases with smear-positive pulmonary TB 
and 20% of HIV-negative culture-positive, smear-negative cases would die within ten years 
without treatment [8]. Although the mortality rate of TB has decreased by 41% since 1990, 
there were an estimated 1.4 million TB-related deaths in 2011 worldwide, which indicates the 
need for improved TB control programs; however, this estimate excludes deaths among HIV 
positive individuals [8].  
 
1.7 The global burden of HIV 
 
HIV is primarily a sexually transmitted virus that impairs the immune system and leads to 
AIDS and death if not treated with antiretroviral therapy (ART). Although the global incidence 
of HIV infection has stabilized and even begun to decline in many countries, there were 
approximately 2.7 million incident cases in 2010, contributing to the 34.0 million people living 
with HIV globally [10]. Sub-Saharan Africa continues to be the region with the highest 
incidence of HIV infection, with an estimated 1.9 million individuals newly infected in 2010 
[10]. Women accounted for approximately 50% and 59% of adults living with HIV worldwide 
and within sub-Saharan Africa respectively [10]. Fortunately, access to ART in low- and 
middle-income countries has increased substantially. Such treatment decreases the risk of 
sexual HIV transmission between sero-discordant couples and may therefore reduce the 
number of new HIV infections [11, 12]. 
 
HIV-related mortality is also steadily decreasing worldwide as a result of increased access to 
ART and improved care and support [10]. However, HIV continues to be the leading cause 
of infectious disease deaths, with approximately 1.8 million AIDS-related deaths in 2010 [10]. 
Despite efforts to reduce global HIV-related mortality rates, specific regions such as the 
Middle East, North Africa, Eastern Europe, and Central Asia still continue to experience high 
rates [10].  
  
1.8 HIV/TB co-infection 
 
HIV is the single most significant predisposing risk factor for developing TB disease [13, 14]. 
HIV/TB co-infection has been denounced the “cursed duet”, whereby HIV infected 
individuals have a significantly increased risk of developing TB disease compared to HIV 
uninfected individuals [13, 14].  In 2011, 13% of all incident TB cases were co-infected with 
HIV and 79% of those co-infected were from the African Region [8]. In addition, 
approximately 30% of TB-related deaths were among HIV-positive individuals [8]. This 
interaction has been substantiated by findings of increased TB case loads in populations 
with high burdens of HIV infection, an increased prevalence of HIV infection among TB 
cases, and an increasing risk of TB disease in people with advancing immunosuppression 
[15]. 
 
1.9 HIV and TB in South Africa 
 
South Africa, located at the southern-most tip of Africa, is a country with nine provinces and 
approximately 50.6 million residents [15]. It is currently faced with one of the worst HIV and 
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TB cases, which accounted for one-quarter of the total burden of TB in sub-Saharan Africa 
[8, 18]. Furthermore, as previously mentioned, South Africa carries the third largest burden 
of TB disease after India and China [8].  
 
While South Africa contains only 0.7% of the world's population, the prevalence of HIV 
continues to be the highest in the world, with approximately 5.6 million people living with HIV 
[10, 17]. The national prevalence of HIV among adults is approximately 16.9%, which varies 
by provinces from 5.3% in the Western Cape province to a dramatically high prevalence of 
25.8% in KwaZulu-Natal province [20].     
 
The interaction between TB and HIV is highly evident in South Africa. South Africa's 
maturing HIV epidemic contributed to a four-fold increase in TB notification rates from 163 
per 100,000 in 1986 to 628 per 100,000 in 2006 [21]. Prior to the onset of the HIV epidemic, 
the Western Cape province had the highest TB rates [17]. Currently, KwaZulu-Natal province 
not only has the highest HIV rates but also some of the highest TB notification rates [17]. 
South Africa’s efforts to control TB have failed given the insufficient TB cure rates and TB 
case detection rates, a generalized HIV epidemic, and deep-rooted social issues such as 
poverty, overcrowding and poor living conditions [17, 22, 23].     
 
Cape Town, located in the Western Cape province, is a socio-economically and ethnically 
diverse city with approximately 3.4 million residents [24]. In 2009 in Cape Town alone, there 
were 29,478 incident TB cases notified; more than half were co-infected with HIV[25]. TB 
notification rates per person in each age group were calculated using absolute TB case 
numbers acquired from routine data and estimated denominators according to National 
Department of Health age- and sex-disaggregated population data and Provincial age- and 
sex-disaggregated HIV prevalence rates. Among HIV negative individuals, there were three 
peak TB notification rates of 511, 553, and 628 per 100,000 among 0-4, 20-24, and 45-49 
year olds, respectively [25]. TB notification rates among HIV positive individuals were 
dramatically higher than rates among HIV negative individuals in each age group. These 
rates gradually increased from 5,253 per 100,000 among 20-24 year olds to a peak of 8,598 
per 100,000 among 40-45 year olds, which then gradually decreased to 7,215 per 100,000 
among 50-54 year olds [25]. Wood et al. [25] reported a 17-fold increased risk of developing 
TB disease if HIV co-infected as opposed to HIV uninfected in this population. The age 
distribution of TB disease parallels the age distribution of HIV disease in this population [25]. 
The burden in people whose HIV status is unknown was not ascertained. 
 
1.10 Gender-based approach to public health 
 
Gender is intrinsically linked to the way individuals experience health outcomes. Differences 
in the susceptibility to disease among males and females can be explained as biologically 
prescribed characteristics or as a socially constructed phenomenon that determines gender 
norms in society and is often associated with stigma, power, barriers, and disparity. 
According to the World Health Organization (WHO), 
 
A gender-based approach to public health begins from the recognition of the 
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health risks, experiences, and outcomes are different for women and men...and to 
act accordingly... [26]     
 
With this framework, public health professionals should examine biological, socio-cultural, 
economic and epidemiological mechanisms driving the differential burden of TB among 
males and females globally and in South Africa.   
 
1.11 Historical TB-related differences between males and females 
 
Historically, males and females have been differentially affected by TB disease. Holmes et 
al.'s [31] 1998 review of sex differences in the epidemiology of TB compared the age-
specific burden of TB disease among males and females in industrialized countries during 
the 1930s to the mid-1950s as well as during the 1970s. Industrialized countries such as 
Denmark (1939-1941), Norway (1937), and England and Wales (1952-1954) reported 
consistent gender differences across age-specific TB notification rates, which showed similar 
rates among male and female children but higher rates among adolescent and young adult 
females followed by higher rates in older adult males [27].  
 
However, as a result of concerted efforts to reduce the burden of TB during the 1970s, TB 
notification rates in these countries fell from a high TB incidence of 100 per 100,000 to a low 
TB incidence of less than 30 per 100,000 [27]. The age and gender pattern of TB disease 
also changed; males of all ages had higher TB notification rates than females [27]. The shift 
in the age-distribution of male and female TB notification rates was also observed in 
Greenland during a period of mobilization by the government to improve public health, a 
lower income country compared to Denmark, Norway, England and Wales [28]. 
 
1.12 Differences between the number of male and female TB cases 
 
Some studies analyzed only absolute TB case numbers and therefore relied primarily on 
ratios. However, these studies showed similar age and gender patterns of TB disease as 
compared to studies which reported age- and gender-specific TB notification rates (which 
will be described in the following section of this review).  
 
Some studies found that the number of male TB cases outnumbered the number of female 
TB cases across all ages. Begum et al. [33] found that females in Bangladesh were less 
likely than males to attend out-patient clinics with respiratory complaints at any age - a gap 
which widened with increasing age, from a female:male ratio of 0.73 among <15 year olds to 
0.18 among ≥65 year olds. A South African study by Austin et al. [34] reported similar 
findings - a male:female ratio of 1.45 among all TB cases and 2.08 among smear-positive 
cases . Among smear-positive TB cases, male:female ratios steadily increased from 1.18 
among 15-24 year olds to 3.64 among 55-64 year olds and then decreased thereafter [30].  
 
Conversely, other studies observed more female than male TB cases at certain ages. 
Crampin et al.'s [35] study conducted in Malawi reported a female:male ratio of 2.6 among 
cases ≤25 years old, which decreased with increasing age. Among HIV positive TB cases, 
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younger female and older male pattern of TB disease in this population more than in HIV 
negative cases [31]. Another South African study by Lawn et al. [14] also described more 
female than male TB notifications among ≤30 year olds, after which age there were more 
male than female TB notifications. Salim et al. [36] reported a female:male ratio of 1.19 
among 0-14 year old TB cases which decreased to 0.54 among ≥65 year olds in 
Bangladesh. This is the only study to find a higher proportion of female to male children 
cases; in all other studies, male and female children had similar burdens of disease.   
 
1.13 Differences between male and female TB notification rates  
 
Today, the age and gender distribution of TB notification rates in the majority of low- and 
middle-income countries which reported disaggregated data mirrors the pattern observed in 
industrialized countries in the 1970s. Jiménez-Corona et al. [37] reported a crude incidence 
rate ratio in males versus females of 1.41, 1.64 and 1.58 among clustered TB cases, 
reactivated TB cases, and total TB cases in Southern Mexico. Borgdorff et al. [38] found that 
crude female:male smear-positive notification rate ratios never exceeded 1.0 and decreased 
with increasing age in nearly all 14 countries analyzed. Holmes et al. [31] reported that age-
specific smear-positive notification rates among males and females in Nicaragua, Kenya, 
Tanzania and China were similar until the age of 14 years, after which males had higher TB 
rates than females. Martinez et al. [39] cited an overall male:female incidence rate ratio of 
2.1(95% confidence interval (CI) 1.9-2.3) from 1991-1996 in America. There were similar 
notification rates among males and females ≤24 years old, after which age rates in males 
≥25 years old were approximately 2-3-fold higher than in females [35]. However, stratifying 
by HIV revealed crude male:female incidence rate ratios of 1.8 (95% CI 1.6-1.9) and 0.5 
(95% CI 0.3-0.8) in HIV negative and HIV positive TB cases respectively, which indicates 
that HIV co-infection significantly increased TB rates among females in this population [35]. 
 
In contrast to the majority of low- and middle-income countries, this literature search 
identified Malawi and Uganda as the only two countries which mirror age-specific TB 
notification rates observed in males and females during the mid-20th century. Borgdorff et al. 
[38] reported female:male notification rate ratios of 1.3 and 1.6 among 15-24 year old 
Malawian females in 1990 and 1996 respectively, which decreased with increasing age. 
Similarly, in 1996, 15-24 year old Ugandan females had a female:male notification rate ratio 
of 1.2, which also decreased with increasing age [34]. While Borgdorff et al.'s [34] study is 
the only one to report this pattern of gender differences in age-specific TB notification rates, 
as previously mentioned, Crampin et al. [31] and Lawn et al. [15] confirmed similar age and 
gender patterns in TB count data.    
 
1.14 Factors causing gender differences in the occurrence of TB disease 
 
1.14.1 Under notification  
 
In countries with low prevalences of HIV, differences in the incidence of TB disease among 
males and females are attributable to under notification of TB cases, sex specific 
mechanisms and epidemiological differences. Research suggests that lower TB notification 
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compared to young females in industrialized countries historically, may be a result of under 
notification. However, these findings are counterintuitive to the expectation of increased TB 
case finding given the advancements in modern technology and public health as well as 
improvements in social and gender inequalities. Despite that, one must remember that these 
findings compare industrialized, wealthier countries to developing, lower income countries, 
which are comprised of different social, economic, and health structures.  
 
The Gender Inequality Index (GII), developed by the United Nations Development 
Programme, provides an index of females' disadvantage over males based on reproductive 
health, empowerment, and labour market indicators [36]. This index ranges from 0 (females 
and males fare equally) to 1 (females fare poorly in all three areas) [36]. The Gini-coefficient 
of inequality is also a commonly used indicator of relative inequality when comparing one 
population to another. This index also ranges from 0 (complete quality) to 1 (complete 
inequality) [37]. According to Dorius and Firebaugh [42], who used the Gini-coefficient, 
gender inequality in education, mortality, political representation, and economic activity has 
been largely declining across the world . However, lower- and middle-income developing 
countries had worse Gender Inequality scores compared to higher-income developed 
countries from 1995-2011. For example, developing countries such as Bangladesh, South 
Africa, Mexico, Nicaragua, Kenya, and Tanzania had scores that ranged from 0.69 in Kenya 
(1995) to 0.49 in South Africa (2011) [36]. In contrast, developed countries such as the 
United Kingdom, Norway, and Denmark had significantly better scores that ranged from  
0.24 (United Kingdom 1995) to 0.06 (Denmark 2011) [36]. Although this index represents 
modern gender inequalities, these scores provide an indication of why under notification of 
females may be worse in lower- and middle-income countries today compared to 
industrialized countries in the mid-20th century. 
 
Researchers largely attributed under notification to lack of access, TB- and HIV-related 
stigma, and health facility characteristics. Holmes et al. [27] described gender inequalities 
towards females such as lack of access to income, legal rights, education, and lower social 
status as potential factors associated with under notification. Onifade et al. [43] found that 
the females' health was not as important as males' health in shantytowns in Peru, which led 
to females accessing healthcare services less than males and potentially living with 
undetected TB. Salim et al. [36] attributed their findings to the strict Muslim beliefs in 
Bangladesh and the tendency for females to have restrictive lifestyles and be dependent on 
their male partners, making it difficult for females to seek health services and be diagnosed 
with TB.  
 
Somma et al.'s [44] study found that various aspects of stigma affected females more than 
males in Bangladesh, Malawi, Colombia, and India. For example, females were more likely 
than males in at least 3 of the 4 countries to desire to keep their TB diagnosis secret, think 
less of themselves, feel ashamed or embarrassed, be concerned that others will think less of 
them, be concerned that others will refuse to visit them, and be concerned that they will have 
problems getting married. In addition, in Malawi, there was HIV-related stigma associated 
with TB disease, whereby symptoms of TB were associated with HIV infection, which 
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Khan et al. [45] assessed the influence of diagnostic centre characteristics on the number of 
male and female TB suspects. The authors found that more females than males sought 
services at facilities that catered to the local catchment area and were accessible on foot, 
whereas facilities that were larger, more centralized, and had evening hours catered more to 
males than females. These findings suggest that facilities that do not cater to the local 
catchment area and are not accessible by foot may deter females from accessing care and 
lead to under notification. According to Begum et al., [33] females tend to utilize private 
healthcare more than public healthcare, which may also explain why fewer females than 
males are notified as TB cases in the public sector. Begum et al. [33] also postulated that 
the high female:male ratio of 0.73 among young TB cases may be a result of increased 
utilization of healthcare services for children's healthcare needs, which enhances the 
likelihood of TB case detection. The authors also proposed that the declining attendance 
among older female TB cases (female:male ratio 0.18) may be because of an increased 
preference for non-Western medicine [29].  
 
However, research done by Balasubramanian et al. [46] in south India refuted the argument 
that lower TB notification rates in young females are a result of under notification. This study 
found that despite greater TB-related stigma and barriers to accessing services, females 
were more likely than males to access services and be notified, while still showing a lower 
prevalence of TB than males. This indicates that other factors besides socially-driven under 
notification may be contributing to lower notification rates among females in some 
populations.  
 
1.14.2 Sex-specific mechanisms 
 
The literature also attributes the higher burden of TB disease in males than in females to 
sex-specific mechanisms that affect susceptibility. Neyrolles et al. [47] described a variety of 
studies that have identified male sex as an independent risk factor for TB disease after 
adjusting for various confounders, which is suggestive of underlying biological mechanisms. 
Davila et al. identified polymorphisms in the X-chromosome associated paradoxically with 
male-restricted susceptibility to TB disease [44]. Mice models also showed that treatment of 
testosterone increased susceptibility to M.marinum and M.intracellulare [45, 46], while 
estrogen decreased susceptibility to M.avium [47]. Neyrolles et al. [43] postulated that 
nutrition and metabolism may also affect susceptibility to TB disease but these factors 
remain largely inconclusive. For example, some studies suggest that high levels of iron may 
increase the risk of TB [48, 49]. Therefore, the lower levels of iron commonly in females may 
provide a protective effect against TB infection in females [43]. Thus, these findings may 
partially explain why males post-puberty have higher rates of TB disease compared to 
females.   
 
1.14.3 Epidemiological factors 
 
Some studies identified epidemiological factors contributing to an increased risk of TB 
among males. Hudelson et al. [54] suggested that the sexual division of labor, cultural 
practices, and socialization patterns in certain countries may affect the risk of exposure to 
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a study conducted in India, which found that males engaged in higher levels of socializing 
while females tended to stay at home or work outside in the fields. As a result, males were 
more susceptible to developing TB disease in this population [50]. Salim et al. [36] also 
observed that Bangladeshi females were more likely to be confined to their homes and 
therefore less likely to engage in social mixing and be exposed to TB infection. In both of 
these settings, restrictive social mixing among females may have led to lower TB rates than 
in males. 
 
In contrast, other studies identified epidemiological factors contributing to an increased risk 
of TB among females. Holmes et al. [31] reported multiple studies which found that females 
of reproductive age have a higher rate of progression from TB infection to TB disease, which 
may partially explain increased TB rates among young females of reproductive age. In 
addition, a South African study found that females rather than males engage in higher levels 
of social mixing, which may reflect a less constrained lifestyle for South African females 
compared to Bangladeshi or Indian females [51]. Crampin et al. [31] reported that having a 
TB case in the family or household increased the risk of both male and female participants 
developing TB themselves, although the risk was higher among females [adjusted Odds 
Ratio (OR) 1.9 (95% CI 1.2-3.1) versus adjusted OR 2.6 (95% CI 1.8-4.0)]. This may be a 
result of females interacting more closely and more frequently with individuals in the 
household compared to males who work longer hours and are away from home more often. 
Therefore, these factors may be increasing the risk of TB exposure and subsequent disease 




While the aforementioned factors may play contributing roles, both Malawi and Uganda had 
high prevalences of HIV during the 1990s [52, 53], and South Africa in recent years [10, 15]. 
Gender differences affect the prevalence of HIV in males and females differently, which in 
turn lead to further differences between males and females in regards to TB disease. This is 
corroborated by Crampin et al. [35] who found that HIV infection exacerbated the younger 
female and older male pattern of TB disease more than HIV negative individuals. In addition, 
Lawn et al. [14] reported that the annual TB notification rates among South African 
adolescents increased from 1996-2004, particularly among females, which they also 
attributed to the maturing HIV epidemic in the study population. HIV's effect on gender 
differences related to TB disease can be explained by HIV-related immunological and health 
systems pathways.  
 
It is well-established that HIV suppresses immune functioning and significantly increases 
susceptibility to developing TB disease. Young people 15-24 years old living in countries 
such as South Africa are at greatest risk of contracting HIV and consequently accounted for 
nearly half of all HIV infections in 2010, of which 80% occurred in sub-Saharan Africa [10, 
54–56]. However, young females in particular have an approximate 2-4-fold increased risk of 
HIV infection than males in HIV-burdened populations [54, 56].  
 
There have been concerted efforts to scale-up HIV services in HIV-burdened countries. For 
example, in South Africa, about 10 million individuals were tested for HIV in 2010 [10, 17] 
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females than males [57]. These statistics indicate that thousands of HIV positive individuals, 
especially disproportionately affected young females, are in the healthcare system, returning 
for follow-up visits, and being monitored. Therefore, they are more likely to be suspected, 
tested, and diagnosed with TB. These factors increase case finding and may also be 
contributing to higher notification rates of TB among young HIV positive females than males 
in this population. Boeree et al. [61] reported that proportionally more females 15-24 years 
old in Malawi submitted sputum for analysis than males of the same age, which they 
attributed to high HIV rates in this population and the strong association between HIV and 
TB. Perhaps the authors were also alluding to the increased level of case finding as a result 
of HIV positive young females being identified by the health system. 
 
The higher burden of TB disease among young females in Malawi, Uganda, and South 
Africa suggest that females may not be experiencing socio-cultural barriers accessing 
services more than males. This contrasts with research from other low- and middle-income 
countries such as Bangladesh where the consistently higher burden of TB disease among 
males is commonly attributed to females' lack of access and under notification of TB [27, 39, 
40, 59]. If females in these populations experienced barriers accessing TB care and were 
therefore under notified, it is likely that we would not observe the excess burden of TB 
disease seen in young females. Thus, it appears as if immunological as well as health 
systems factors outweigh any socio-cultural barriers preventing females from accessing 
services in these populations. Furthermore, HIV positive individuals are more likely to be 
smear-negative and are therefore difficult to diagnose [60], which provides evidence for 
speculation of an even larger burden of TB disease among HIV positive young females with 
undetected TB in these countries.   
 
1.15 Differences between the clinical characteristics of male and female TB cases 
 
1.15.1 Sputum submission 
 
Sputum submission in this context refers to requests from health professionals for TB 
suspects to provide sputum samples for analysis. There were differing findings related to the 
ratio of female to male TB suspects who submitted sputum for analysis. Begum et al. [33] 
cited an overall female:male ratio of 0.51 for sputum submission, which decreased from 0.73 
among <15 year olds to 0.18 among ≥65 year olds. Similarly, Boeree et al. [61] reported an 
OR in males versus females of 1.15 (95% CI 1.12-1.19) among participants in Malawi. 
Austin et al. [34] found that males submitted proportionally more sputum tests than females 
across all ages. There was a minor difference in the number of sputum tests requested 
between male and female adolescents and young adults, an increasing difference between 
middle-aged males and females, and receding differences between older adults [30].  
 
The literature describes individual- and provider-level factors associated with decreased 
sputum submission among females. Some authors have suggested that provider bias 
leading to a higher index of suspicion of TB disease among males may explain why females 
are less likely than males to be asked to submit sputum [29, 30, 61]. Another author found 
that the primary reason for not submitting sputum for analysis was the inability to produce 
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or socially constructed standards for females and how they should conduct themselves in 
public, which may lead to females' reluctance to expectorate sputum out of fear of 
embarrassment [63].  
 
In contrast, although Boeree et al.'s [61] crude association indicated that males had a higher 
likelihood of submitting sputum, an age stratified analysis revealed that there were 
significantly more female than male TB suspects 15-24 years who submitted sputum. 
Furthermore, Begum et al. [33] reported that the number of sputum samples taken were 
similar between males and females, although the data were not shown in the article.  
 
As mentioned above, Boeree et al. [61] linked the increase in sputum submissions among 
young females to the disproportionate effect of HIV on young females in Malawi, which may 
have resulted in an increased usage of healthcare services and therefore increased 
opportunities to identify female suspects and request sputum samples for analysis. Begum 
et al.'s [59] findings, also from Malawi, may also be associated with HIV, which may have 
increased the number of females submitting sputum and shifted female:male ratio closer to 
unity. 
 
1.15.2 Sputum smear-positivity 
 
Studies consistently found that females were less likely than males to be sputum smear-
positive at any age, except for one study that identified a higher smear positivity rate among 
young females. Begum et al. [33] reported an overall female:male ratio of 0.36 among 
smear-positive cases, which ranged from 0.89 among <15 year olds to 0.03 among ≥65 year 
olds . Boeree et al. [58] and Austin et al. [30] found that males had a higher odds of being 
smear-positive than females [OR=1.31 (95% CI 1.19-1.44) and OR=1.54 respectively] [30, 
58]. In addition, as previously mentioned, the male:female ratio among Austin et al.'s [34] 
smear-positive cases increased from 1.18 among <25 year olds to 3.64 among 55-64 year 
olds . However, while Salim et al. [36] reported a smear positivity female:male rate ratio of 
0.35 overall, an age and gender stratification revealed a higher smear positivity rate among 
females 15-24 years than males (female:male rate ratio 1.39) but a lower smear positivity 
rate in all other ages.  
 
In addition, Austin et al. [34] also showed that among the 10% of confirmed cases with 
smear positivity grading recorded, males had increasingly severe positivity than females, 
which ranged from a male:female ratio of 1.8 among those who had an acid-fast bacilli (AFB) 
count of + (10 to 99 AFB per 100 fields) to 2.5 among those who had an AFB count of +++ 
(>10 AFB per field in at least 20 fields) . However, this was the only study to conduct this 
analysis.   
 
The literature suggests that individual-level factors may reduce the likelihood of females 
being smear positive. Begum et al. [33] reported anecdotal evidence which suggests that 
females are less likely to produce "good quality" sputum , which may lead to increased false 
negative smear results. As previously mentioned, "Poor quality" sputum may be a result of 
physical or social barriers to expectorating sputum, which may result in fewer bacilli. Begum 
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indication that females have a lower prevalence of TB compared to males, rather than a 
result of the aforementioned barriers .  
 
In addition, it is also well-established that HIV-related immunosuppression often leads to 
widespread dissemination of TB and reduced cavitation [13, 64]. As a result, expectorating 
sputum becomes more difficult and sputum tends to contain a low bacillary load, which leads 
to diagnostic obstacles [13]. Given that HIV disproportionately affects females, females are 
therefore more likely to be immune suppressed and have extra pulmonary TB, which may 
also explain why fewer Malawian, Ugandan, and South African females than males are 
smear-positive. 
    
4.0 GAPS IN THE LITERATURE 
 
In 1996, Hudelson [54] highlighted the gaps in knowledge and understanding about gender 
differences in TB disease, which was addressed in 1998 by Holmes et al.'s [31] review. 
However, subsequent research has been scarce as well as inconclusive, which led WHO in 
both 2011 and 2012 to emphasize the need for improved reporting of TB data disaggregated 
by age and gender [8, 70].  
 
Among countries which published disaggregated TB disease data, there were two age and 
gender distributions of TB disease identified - one that is ubiquitous and another that is 
reported by only three countries. However, very few studies have confirmed the age and 
gender distributions described or the risk factors associated with these two patterns of TB 
disease worldwide.  
 
Despite the inherent differences in susceptibility to TB and HIV among males and females as 
well as the strong association between the two diseases, few studies conducted in HIV-
burdened settings such as South Africa have explored gender differences related to TB 
disease, nor  how HIV infection effects these gender differences. In South Africa, there has 
only been one in-depth study published on TB-related gender differences by Austin et al. but 




In conclusion, the dual epidemic of HIV and TB is plaguing low- and middle-income countries 
around the world. Yet despite that gender is intrinsically linked to both diseases, few studies 
have been published in high-burdened countries and no study has investigated the effect of 
HIV on TB-related gender differences. The scarce literature on epidemiological differences in 
TB disease between males and females has identified differences in the occurrence of TB 
disease and differences in clinical characteristics. The majority of countries which have 
published papers on this subject have reported that rates in children are similar among 
males and females, after which age male rates significantly exceed female rates throughout 
adolescence and adulthood. However, Malawi, Uganda and South Africa have identified a 
different pattern of TB disease whereby younger females are more affected by TB disease 
than younger males. In addition, females are less likely than males to present to clinic, 
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differences have largely been attributed to biology, epidemiology, and health seeking 
behaviors. However, our hypothesis is that HIV is largely responsible for females’ increased 
risk of developing TB or being notified as TB cases in high-HIV burdened countries including 
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Males and females are differentially affected by tuberculosis (TB) disease. Despite South 
Africa’s dual epidemic, no study has investigated the effect of HIV on TB-related gender 
differences. We hypothesized that the increased burden of TB disease among young 
females in Cape Town is primarily due to HIV infection in this age group. Our objectives 
were to describe Cape Town TB cases; explore associations between gender and clinical 




From 1 January to 31 December, 2009, City of Cape Town TB clinics prospectively collected 
routine notification data on 29,478 new cases. These data were analysed using descriptive 
statistics, bivariate analyses, standardized female:male ratios, regression modelling and TB 




The crude female:male ratio among cases was 0.83. Among 15-54 year old adult cases, 
females were significantly younger than males and less likely than males to have pulmonary 
TB, have smear results recorded, be smear-positive, or have advanced smear-positivity 
grading. Females were more likely than males to be HIV-positive. HIV co-infection widened 
pre-existing clinical differences between male and female cases. Among HIV-negative 
adults, age-specific male notification rates exceeded female rates at all ages to a 2.5-fold 
difference among 45-49 year olds. The rate in 15-19 year old HIV-positive females was 
12.4% higher than in males of that age, after which male rates increasingly exceeded female 
rates to a 2-fold difference among 45-49 year olds. The disparity between male and female 




The age and gender pattern of TB disease in the HIV-positive population has only been 
reported in Malawi, Uganda, and mid-20th century countries. The HIV-negative pattern 
mirrors gender differences in all other countries reporting disaggregated data. HIV co-
infection is associated with an increased risk of TB disease, particularly among young 
females, and has led to decreased gender differences. Controlling for HIV did not nullify 
gender differences, which indicates that there are additional contributing factors. This study 
warrants improved HIV and TB testing and treatment practices as well as educational 
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3.0 BACKGROUND 
 
HIV is considered the single most important predisposing risk factor for tuberculosis (TB) [1–
3]. This is particularly relevant for South Africa, which, despite concerted efforts, continues to 
have one of the worst dual epidemics of TB and HIV globally [4]. In 2012, South Africa 
reported approximately 400,000 incident TB cases, which accounts for one-quarter of all 
incident cases in sub-Saharan Africa [5, 6]. In addition, South Africa has the highest number 
of individuals living with HIV in the world at 5.6 million [7]. In Cape Town, South Africa, a city 
of about 3.4 million residents [8], there were nearly 30,000 incident TB cases notified in 
2009, of whom 51% were HIV positive [9]. Wood et al. [9] found that HIV positive individuals 
living in Cape Town had a 17-fold increased risk of developing TB disease compared to HIV 
negative residents.  
 
Gender, and the biological, social, and cultural factors associated with it, is intrinsically linked 
to TB. According to international literature, male and female children typically have similar 
TB notification rates while adolescent and adult males and females have different TB 
notification rates [10]. Data from industrialized countries from the 1930s to 1950s 
consistently showed that young females 15-34 years old had higher TB notification rates 
than young males and older males ≥35 years old had higher TB notification rates than older 
females [10]. As a result of effective TB control during the 1970s, TB notification rates in 
both males and females in industrialized countries significantly decreased [10]. In addition, 
the age and gender pattern of TB disease shifted; after childhood, TB notification rates in 
males significantly exceeded TB notification rates in females and the higher rates previously 
seen among young females diminished [10].   
 
TB notification rates and the absolute number of TB cases in  the majority of low- and 
middle-income countries today which report disaggregated data are similar in magnitude to 
what was reported in industrialised settings during the 1930s-1950s; however, the age and 
gender distribution is more similar to distributions reported during the 1970s [10–15]. The 
consistently higher TB notification rates among adolescent and adult males has been 
partially attributed to under notification of female TB cases resulting from lack of access to 
TB services [10, 11, 16]; insufficient funds [10]; poor education [10]; a lower priority placed 
on women's health [17]; and fear of social isolation or rejection [18]. In addition, biological 
factors such as higher levels of testosterone from the onset of puberty may be contributing to 
males’ increased susceptibility to TB disease and the subsequently higher TB notification 
rates in adolescent and adult males [12]. Lastly, in some populations males engage in more 
frequent social interactions than females and are therefore at higher risk of TB exposure and 
transmission, which may also be contributing to the higher notification rates seen among 
males [19].  
 
In contrast, studies show that the magnitude of TB disease in Malawi, Uganda, and South 
Africa, as well as the corresponding age-specific gender differences, are comparable to the 
burden seen in mid-20th century industrialized societies [15, 20, 21]. At the time these data 
were collected, Malawi, Uganda, and South Africa had high prevalences of HIV [7, 21–23]. 
Given that HIV disproportionately affects young females and is strongly associated with TB, 
it is most likely a major contributing factor associated with the age and gender pattern of TB 
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rather than males engage in higher levels of social mixing, which may also partially explain 
why young females have higher TB notification rates than males in this population [24]. 
 
Apart from risk, male and female TB cases also differ by clinical characteristics. Females are 
typically less likely than males to be asked by health professionals to submit sputum 
samples for investigation [11, 14, 25]. This may be a result of health professionals having a 
higher index of suspicion towards males due to the belief that males are at higher risk of 
developing TB disease than females [11, 14]. Females who submit sputum are less likely 
than males to be smear-positive [11, 14, 25], which may be partially attributable to females 
being less able, or less likely as a result of socio-cultural barriers, to expectorate sputum 
[11]. In HIV-burdened countries, HIV-related immune suppression often leading to the 
development of extra-pulmonary TB, a lack of cavitation and lower bacillary loads may also 
contribute to females being less smear-positive than males [2, 26, 27].  
 
Despite the ever growing pool of knowledge that gender is a major determinant of health 
outcomes, gender has been a neglected aspect of TB research; the most recent review on 
gender and TB disease was published by Holmes et al. [10] in 1998. Furthermore, although 
HIV is a major risk factor for TB disease, few studies conducted in HIV-burdened countries 
including South Africa have addressed the effect of HIV on gender differences in regards to 
TB disease. Significantly improved HIV testing rates [9, 28] and new guidelines to record HIV 
information for TB cases has enabled us to effectively explore these aspects of TB disease 
in Cape Town, South Africa for the first time. We hypothesize that the increased burden of 
TB disease among young females in Cape Town is primarily due to HIV infection in this age 
group. 
 
Therefore, this study aims to: (a) describe the 2009 Cape Town TB case population by age, 
gender, and HIV and determine corresponding standardized female:male ratios; (b) explore 
associations between gender and clinical characteristics of TB cases and the impact of HIV 
on these associations; (c) estimate age-specific TB notification rates by gender and HIV and 
determine corresponding notification rate ratios (NRRs); and (d) draw conclusions regarding 
the impact of HIV on observed gender differences. Through this research, we hope to gain a 
better understanding of how HIV positive as well as HIV negative males and females 
experience TB disease, which may provide insights for a multi-pronged approach to TB 
control in South Africa that considers the effects of age, gender, and HIV. 
4.0 METHODS 
4.1 Study population 
 
TB clinics, located throughout the eight City of Cape Town districts, offer free TB screening, 
diagnosis, and Directly Observed Therapy, Short-course (DOTS) treatment as per the South 
African national TB guidelines [29]. In all City of Cape Town TB clinics, a standardized paper 
TB register is used to collect demographic information, disease classification, treatment 
regimen, monitoring, and outcomes for all TB cases. This information is then collated into a 
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From January 1, 2009 to December 31, 2009 there were 31,093 TB cases prospectively 
recorded in the electronic TB register. Of those, 1,615 cases had transferred in or moved in 
to City of Cape Town clinics during their course of treatment and were excluded from this 
analysis. Thus, this analysis included 29,478 newly registered TB cases who commenced on 
TB treatment at City of Cape Town TB clinics during the study period. Cases were 
categorized into 16 five-year age strata ranging from 0 to ≥75 years. 
 
4.2  Ethics approval 
 
This study was approved by the Faculty of Health Sciences Health Research Ethics 
Committee, University of Cape Town, and the City of Cape Town City Health directorate. No 
informed consent was obtained from patients, as this study used routinely collected TB data 
per South African national TB guidelines and all personal identifiers were removed prior to 
analysis. 
 
4.3  Statistical analysis 
 
These data were analyzed using Microsoft Excel and STATA 11.0 (StataCorp, College 
Station, Texas). Descriptive statistics were employed to summarize demographic and clinical 
characteristics of TB cases. Bivariate analysis using appropriate hypothesis testing was 
employed to interpret differences between proportions of male and female TB cases. 
Logistic and multinomial regression modelling was employed to explore associations 
between gender and clinical characteristics of TB cases, while adjusting for potential 
confounders such as age and HIV. 
 
Age-specific female:male ratios of TB cases were divided by the overall crude female:male 
ratio of TB cases to determine a standardized female:male ratio for each age stratum. A 
standardized female:male ratio >1.0 indicates a larger proportion of female cases than 
expected in a particular age group, whereas a standardized female:male ratio <1.0 indicates 
a smaller proportion of female cases than expected for a particular age group, using the 
overall crude ratio as the expected value. 
 
Cases were considered HIV positive if they were recorded in the TB register as being HIV 
positive or met any of the following criteria: had a CD4 count recorded, were on antiretroviral 
therapy or had been given cotrimoxazole prophylaxis. Cases were considered HIV negative 
if they were recorded as HIV negative and did not meet any of the criteria for being HIV 
positive. Lastly, cases were considered HIV unknown if they had inconclusive HIV-related 
information. 
 
TB cases with indeterminate HIV information were apportioned as: (A) HIV positive, (B) HIV 
negative, and (C) HIV positive or HIV negative according to existing HIV rates among TB 
cases with known HIV statuses. Under scenario C, for each age stratum, the true number of 
HIV unknown TB cases was multiplied by the HIV rate in TB cases with known HIV results 
and the product was added to the true number of HIV positive TB cases to yield the 
estimated number of HIV positive cases.  
 
To estimate age- and gender-specific Cape Town population denominators stratified by HIV, 
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gender-specific HIV prevalence in the Western Cape acquired from the Actuarial Society of 
South Africa (ASSA) model [30, 31]. A sensitivity analysis to compare TB notification rates 
given scenarios A, B and C showed little variation between scenarios (analysis not shown, 
but available in Table 3 in the Appendices). Therefore, scenario C was selected as the most 
probable distribution of HIV infection among cases 15-54 years old. Poisson regression 
modelling was conducted to estimate 2009 TB notification rates per 100,000 by age, gender 
and HIV as well as TB notification rate ratios (NRRs) comparing genders, while adjusting for 




5.1 TB case population 
 
5.1.1 All cases 
 
In 2009, there were 29,478 newly registered TB cases treated at 99 clinics throughout the 
eight Cape Town districts. Less than half (45.4%) of all cases were female (13,379/29,478), 
which yielded a crude female:male ratio of 0.83 (p<0.001). Male cases were a median age of 
34 years old with an interquartile range (IQR) of 24-44 years old. Female cases were 
significantly younger than male cases, with a median age of 29 years old and an IQR of 21-
38 years old (p<0.001). There were significantly different numbers of male and female cases 
across 5-year age strata (p<0.001), which is shown in the age distribution of male and 
female cases in Figure 1. There were two peak age-specific notifications; the first peak 
occurred in male and female cases 0-4 years old (n=1,456 vs. n=1,397), and the second 
peak occurred among females 25-29 years old (n=2,341) and males 35-39 years old 
(n=2,321). (A table of TB cases stratified by age, gender and HIV is available in the 










































Figure 1 shows two peak caseloads among males and females. The first peak occurred among 
0-4 year old males and females, and the second peak occurred among 25-29 year old females 
and 35-39 year old males. There were more female than male cases 15-29 years old. 
 
5.1.2 Child cases (0-14 years old) 
 
The differences in demographic and clinical characteristics between male and female child 
cases (0-14 years old), adult cases (15-54 years old), and older adult cases (≥55 years old) 
are shown in Table 1. Of the total TB cases, 13.5% (3,968/29,478) were children 0-14 years 
old. Between male and female children, there was no significant difference in the number of 
cases (p=0.71), age (p=0.21), disease classification (p=0.26), smear positivity grading 
(p=0.64), and HIV status (p=0.06). Although there was a significant difference in smear 
results, the majority of data on smear results were missing. 
 
5.1.3 Older adult cases (≥55 years old) 
 
Older adults ≥55 years old accounted for 6.7% (1,986/29,478) of total TB cases. Female 
older adults were a median age of 61 years old (IQR=57-68 years old) and significantly older 
than males who were a median age of 59 years old (IQR=57-64 years old) (p<0.001). 
Between male and female older adults, there was no significant difference in the number of 
cases (p=0.05), disease classification (p=0.68), sputum smear results (p=0.96), and HIV 
status (p=0.08). However, standardized female:male ratios decreased significantly with 
increasing sputum smear positivity (the number of acid-fast bacilli present in sputum) from 
1.51 among cases who were scanty positive, to 1.43 among those who were P+, 1.07 





















Figure 1 - Male and female tuberculosis cases by five-year age strata  
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Table 1 – Demographic and clinical differences between male and female tuberculosis cases - children (0-14 years old), adults (15-54 years old), and older adults (≥55 years old) 
 Children (0-14 years old) Adults (15-54 years old) Older adults (≥55 years old) 
 Male Female P-value Male Female P-value Male Female P-value 
N  1,998 1,970 0.71† 12,827 10,697 <0.001† 1,274 712 0.05† 
Age (years), med (IQR) 2 (1-5) 3 (1-5) 0.21† 35 (28-42) 31 (25-38) <0.001† 59 (57-64) 61 (57-68) <0.001† 
Disease classification  0.26‡ <0.001‡ 0.68‡ 
Pulmonary TB 1,849 (92.5) 1,848 (93.8) 10,919 (85.1) 8,427 (78.8) 1,075 (84.4) 603 (84.7)
Extra-pulmonary TB 137 (6.9) 114 (5.8) 1,679 (13.1) 2,020 (18.9) 183 (14.4) 97 (13.6)
Both 12 (0.6) 8 (0.4) 229 (1.8) 250 (2.3) 16 (1.3) 12 (1.7)
Smear results*  <0.001‡ <0.001‡ 0.96‡ 
Smear-negative 134 (7.2) 139 (7.5) 3,970 (35.6) 3,802 (43.8) 476 (43.6) 273 (44.4)
Smear-positive 57 (3.1) 134 (7.2) 6,727 (60.3) 4,414 (50.9) 547 (50.1) 304 (49.4)
No data 1,670 (89.7) 1,583 (85.3) 451 (4.1) 461 (5.3) 68 (6.2) 38 (6.2)
N 1,861 1,856 11,148 8,677 1,091 615
Smear grading**  0.64‡‡ <0.001¥ 0.002¥ 
Scanty 2 (3.5) 10 (7.6) 209 (3.1) 193 (4.4) 20 (3.7) 17 (5.6)
P+ 14 (24.6) 38 (28.4) 1,229 (18.3) 1,043 (23.6) 92 (16.8) 73 (24.0)
P++ 9 (15.8) 24 (17.9) 1,043 (15.5) 718 (16.3) 86 (15.7) 51 (16.8)
P+++ 26 (45.6) 54 (40.3) 3,737 (55.6) 2,070 (49.6) 290 (53.0) 130 (42.8)
No data 6 (10.5) 8 (6.0) 509 (7.6) 390 (8.8) 59 (10.8) 33 (10.9)
N 57 134 6,727 4,414 547 304
HIV status  0.06‡ <0.001‡ 0.08‡ 
HIV negative 1,085 (54.3) 1,096 (55.6) 5,819 (45.4) 3,257 (30.5) 803 (63.0) 447 (62.8)
HIV positive  245 (12.3) 276 (14.0) 5,643 (44.0) 6,647 (62.1) 258 (20.3) 168 (23.6)
HIV unknown 668 (33.4) 598 (30.4) 1,365 (10.6) 793 (7.4) 213 (16.7) 97 (13.6)
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5.1.4 Adult cases (15-54 years old) 
 
More than three-quarters (23,524/29,478) of total TB cases were adults 15-54 years old. 
Male and female cases were significantly different across all demographic and clinical 
characteristics presented in Table 1 (p<0.001).  
 
In this group, there was a larger proportion of male than female cases overall (standardized 
female:male ratio=0.83). In addition, males were older than females [median age 35 years 
old (IQR=28-42 years old) versus median age 31 years old (IQR=25-38 years old)].  
 
In terms of clinical characteristics, a larger proportion of male than female cases had 
pulmonary TB (standardized female:male ratio=0.93), while a larger proportion of female 
than male cases had extra-pulmonary TB (standardized female:male ratio=1.44) and both 
pulmonary and extra-pulmonary TB (standardized female:male ratio=1.28). Of the cases 
with pulmonary TB, a larger proportion of female than male cases had no smear results 
recorded (standardized female:male ratio=1.29). Among those with results recorded, a larger 
proportion of female than male cases were smear-negative (standardized female:male 
ratio=1.23). Of the cases with smear-positive pulmonary TB, standardized female:male 
ratios decreased with increasing smear positivity from 1.42 among those who were scanty 
positive, to 1.29 among those who were  P+, 1.05 among those who were P++, and 0.89 
among those who were P+++  (p<0.001, test for trend).  
5.1.5 HIV-stratified analysis 
 
Since HIV predominantly affects younger and middle aged adults (15-54 years old) via 
sexual transmission, children (0-14 years old) and older adult (≥55 years old) cases were 
excluded from this analysis.  
 
Among adult cases, a significantly greater proportion of males than females were HIV 
negative (standardized female:male ratio=0.67) and HIV unknown (standardized 
female:male ratio=0.70), while a greater proportion of females than males were HIV positive 
(standardized female:male ratio=1.41) (p<0.001). Age distributions for HIV positive and HIV 
negative male and female adult cases 15-54 years old are presented in Figures 2a and 2b 
respectively. Figure 2a shows that among HIV positive TB cases, the peak number of female 
cases occurred among 25-29 year olds (n=1,697) while the peak number of male cases 
occurred among 35-39 year olds (n=1,398). The age distribution of HIV negative TB cases 
(Figure 2b) shows a very different pattern with much smaller peaks. The first peak among 
20-24 year olds consisted of 711 female cases and 982 male cases, followed by a slight 
second peak in female cases 40-44 years old (n=351) and in older male cases 45-49 years 
old (n=733). 
 
A graphical representation of standardized female:male ratios among HIV positive, HIV 
negative, and HIV unknown TB cases 15-54 years old is shown in Figure 3. While 
standardized female:male ratios among HIV negative and HIV unknown cases peaked at 
similar ratios of 1.55 and 1.62 respectively, HIV positive cases had a dramatically higher 
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Figure 2a shows that the highest number of HIV positive female cases was among 25-29 year 



























Figure 2b shows that HIV negative males and females had a peak number of cases among 20-
24 year olds followed by a slight peak among 40-44 year old females and 45-49 year old males. 



























Figure 2b - HIV negative male and female tuberculosis cases by five-

























Figure 2a - HIV positive male and female tuberculosis cases by five-year 






















Figure 3 shows that HIV negative, HIV unknown, and HIV positive TB cases had peak 
standardized female:male ratios of 1.55, 1.62 and 5.96 among 15-19 year olds respectively, 
which decreased with age. *Standardized female:male ratios were determined by dividing age-
specific female:male ratios by the overall crude female:male ratio of 1.15, 0.62 and 0.66 among 
HIV positive, HIV negative and HIV unknown TB cases respectively.  
 
5.1.6 Associations between female cases and clinical characteristics  
 
Section 5.1.4 describes crude clinical differences between males and females whereas this 
section describes associations between female cases and clinical characteristics adjusted 
for HIV. Table 2 shows unadjusted and adjusted associations between gender and clinical 
characteristics in five regression models. Unadjusted associations were stronger than 
adjusted associations across all characteristics investigated except HIV status. 
 
Females were more likely than males to have extra-pulmonary TB rather than pulmonary TB 
(adjusted odds ratio (OR)=1.22; 95% Confidence Interval (CI)=1.13–1.32). Females were 
less likely than males to have a smear microscopy result recorded in the electronic TB 
register (adjusted OR=0.80; 95% CI=0.72–0.89). Of those with smear microscopy results 
recorded, females were less likely than males to be smear-positive (adjusted OR=0.77; 95% 
CI=0.73–0.83). The odds of having severe smear positivity grading decreased in females. 
When comparing females to males, females had a higher odds of being P+ versus scanty 
positive (adjusted OR=1.03; 95%CI=0.82–1.28), which shifted to a lower odds of being P++ 
versus scanty positive (adjusted OR=0.84; 95%CI= 0.67-1.06) and P+++ versus scanty 
positive (adjusted OR=0.72; 95%CI=0.58–0.89). In addition, females had a 2.48-fold 



























Figure 3 - Standardized female:male ratios* among HIV positive, HIV 
negative and HIV unknown tuberculosis cases (15-54 years old)
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classification     
1 
Pulmonary TB 1.00  NA 1.00†  NA 
Extra-pulmonary TB 1.42 (1.33-1.52)  <0.001 1.22† (1.13-1.32)  <0.001 
Both 1.34 (1.12-1.59)  0.001 1.13† (0.93-1.37)  0.22 
 Smear microscopy 
results     
2 
Test not done 1.00  NA 1.00‡  NA 
Test done 0.75 (0.71-0.80)  <0.001 0.80‡ (0.72-0.89)  <0.001 
3 
Smear negative 1.00  NA 1.00‡  NA 
Smear positive 0.71 (0.67-0.74)  <0.001 0.77‡ (0 .73-0 .83) <0.001 
4 
Scanty positive 1.00 NA 1.00‡  NA 
P+ 0.93 (0.77-1.13)  0.49 1.03‡ (0.82-1.28)  0.83 
P++ 0.75 (0.61-0.91)  0.005 0.84‡ (0.67-1.06)  0.14 
P+++ 0.60 (0.50-0.72)  <0.001 0.72‡ (0.58-0.89)  0.002 
5 
HIV status     
Negative 1.00  NA 1.00¥  NA 
positive 2.24 (2.12 - 2.37)  <0.001 2.48¥ (2.34 - 2.64) <0.001 
*OR=Odds ratio for females compared to males derived from logistic and multinomial regression models. 
†Adjusted for age and HIV status; ‡Adjusted for age, HIV status and disease classification; ¥Adjusted for 
age. 
 
5.2 Cape Town population denominators 
 
In 2009, there were approximately 3,044,010 Cape Town residents, of which 50.2% 
(1,728,714/3,044,010) were female (crude female:male ratio=1.01). Among residents, 5.85% 
were HIV positive, of which 61.1% (123,094/201,502) were female (p<0.001). The Cape 
Town population by age and HIV status has been previously described by Wood et al. [9] 
and a table of the Cape Town population stratified by age, gender and HIV is shown in the 
Appendices, Table 2. 
5.3 Estimated TB notification rates 
 
Less than one-tenth of TB cases were HIV unknown, of which 63.25% (1,365/2,158) were 
male. The age-specific distribution of 15-54 year old HIV unknown male and female TB 
cases was similar to the HIV negative age distribution for male and female TB cases shown 
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The Poisson regression model estimated an overall unadjusted NRR for TB in females 
compared to males of 0.84 (95% CI=0.82-0.86). However, an HIV-stratified analysis 
revealed that HIV modified the association between gender and TB notification rates. In the 
HIV positive sub-population, TB notification rates in females were 12.4% higher than males, 
although this did not reach statistical significance (adjusted NRR=1.12; 95%CI=0.99-1.28). 
In contrast, in the HIV negative sub-population, TB notification rates in females were 12.9% 
lower than in males (adjusted NRR=0.87; 95%CI=0.78-0.97).  
 
Estimated age-specific TB notification rates per 100,000 for HIV positive and HIV negative 
males and females are shown in Figures 4a and 4b respectively. In addition, Table 4 in the 
Appendices provides an age-specific breakdown of TB notification rates per 100,000 by age, 
gender, and HIV. Figure 4a shows a small peak in TB notifications among HIV positive 
males and females 15-19 years, which was 12.4% higher in females (7,380 per 100,000 vs. 
6,568 per 100,000). Thereafter, TB notification rates in females 20-54 years old decreased 
and remained relatively stable, with the exception of a second peak notification of 7,827 per 
100,000 among 40-44 year olds, which was slightly higher than the first peak notification. In 
contrast, notification rates among males ≥20 years old increasingly exceeded female 
notification rates and peaked at 13,397 per 100,000 among 40-44 year olds, which was 
71.2% higher than the notification rate in females of the same age. The most disparate 
notification occurred among 45-49 year olds, where the notification rate in males nearly 
doubled the notification rate in females of the same age.  
 
Figure 4b indicates that HIV negative individuals have lower TB notification rates overall as 
well as a different age and gender pattern compared to HIV positive individuals. Unlike the 
HIV positive population, HIV negative TB notification rates in females did not exceed male 
rates at any age. In addition, HIV negative peak TB notification rates occurred five years 
later than HIV positive peak TB notification rates. In addition, the disparity between HIV 
negative TB rates in males and females was larger than observed among HIV positive 
individuals.  
 
In contrast to 15-19 year old HIV positive females, 15-19 year old HIV negative females had 
a TB notification rate 12.9% lower than the rate among males of the same age. TB 
notification rates peaked among 20-24 year olds at 757 per 100,000 in males and 515 per 
100,000 in females. Thereafter, rates in females remained relatively stable, with the 
exception of a slight peak of 410 per 100,000 among 45-49 year olds. Males in their mid-
30s, on the other hand, had rates that substantially increased to a peak of 1,018 per 100,000 
among 45-49 year olds. The disparity between HIV negative male and female TB notification 



























Figure 4a shows that the TB notification rate among 15-19 year old females was 12.4% higher 
than the rate in males of the same age. Thereafter, rates in males increasingly exceeded rates 
in females, which peaked among 40-44 year olds. Rates in males 45-49 years old was 2-fold 






















Figure 4b shows that the TB notification rates among HIV negative females did not exceed 
male rates at any age. Males and females had peak rates among 20-24 year olds and 45-49 year 
































Figure 4a - Estimated age-specific tuberculosis notification rates in 






























Figure 4b - Estimated age-specific tuberculosis notification rates in 
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6.0 DISCUSSION 
 
This study analysed nearly 30,000 newly notified TB cases and estimated corresponding TB 
notification rates in Cape Town during 2009. Our findings confirm that there are significant 
differences in the age-specific absolute number of male and female TB cases and in the TB 
notification rates among males and females, which are significantly affected by HIV co-
infection. In contrast to the majority of low- and middle-income countries which reported 
disaggregated data, the age and gender pattern TB disease in this population is similar to 
that observed in Malawi, Uganda and mid-20th century industrialized countries such as 
England and Wales [10, 15, 20]. In addition, our findings substantiate the age and gender 
pattern of TB notifications in South Africa reported by Lawn et al. [21] using a more accurate 
measure of TB notification rates. 
 
Stratifying by HIV revealed that HIV is having a significant heterogeneous effect on the age-
specific distribution of TB notification rates in males and females in this population. In the 
HIV positive sub-population, young females 15-19 years old have a higher TB notification 
rate than young 15-19 year old males, after which age male rates increasingly exceed 
female rates throughout adulthood. This pattern of TB disease is similar to what has been 
reported in Malawi, Uganda and industrialized countries during the 1930s-1950s [10, 15, 20, 
21]. In contrast, in the HIV negative sub-population, female TB notification rates never 
exceed male rates at any age; instead, male rates increasingly exceed female rates after 
childhood. This pattern of TB disease is similar to what has been reported in the majority of 
low- and middle-income countries [10, 13, 15, 32]. This is the first study to ascertain that HIV 
co-infection narrows the overall disparity between male and female TB notification rates and 
moves notification rate ratios closer to parity compared to rate ratios for HIV negative 
individuals. HIV co-infection even reverses the TB notification rates among young people: 
young HIV positive females have higher TB rates than young HIV positive males, whereas 
young HIV negative females have lower TB rates than young HIV negative males. Thus, the 
high TB burden among young females in this population is largely attributable to the high 
prevalence of HIV in these individuals. 
 
In addition, we also identified clinical differences between male and female TB cases, which 
were consistent with findings elsewhere. In this population, fewer females than males have 
smear results recorded, which we considered an indicator of sputum submission [11, 25]. 
Among the females who had smear results recorded, they were less likely than males to be 
diagnosed as smear-positive or have severe smear positivity grading [11, 14, 25]. This is the 
first study to report that HIV co-infection consistently widens pre-existing clinical differences 
between males and females.  
 
HIV's effect on TB-related gender differences can be explained by HIV-related 
immunological and health systems pathways. It is well-established that HIV suppresses 
immune functioning and significantly increases susceptibility to developing TB disease. 
Young South Africans 15-24 years old comprise the age group most at risk of HIV infection 
[33, 34]. Young females in particular have an approximate 4-fold increased risk of HIV 
infection compared to males in this population [34]. These factors may explain why young 
HIV positive females in this population have higher TB notification rates than their male 
counterparts. In addition, immunosuppression often leads to widespread dissemination of TB 
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and sputum tends to contain a low bacillary load, which leads to diagnostic obstacles [2]. 
This may explain why fewer females than males in this population have smear microscopy 
results recorded and are smear-positive.   
 
As a result of massive efforts to scale-up HIV services in South Africa, about 10 million 
individuals were tested for HIV in 2010 [4, 7] and 1.79 million HIV positive individuals 
received ART in 2011, of which there were more females than males [35]. These statistics 
indicate that thousands of HIV positive individuals, especially disproportionately affected 
young females, are in the healthcare system, returning for follow-up visits and being 
monitored. Therefore, they are more likely to be suspected, tested, and diagnosed with TB. 
These factors increase case finding and may also be contributing to the higher TB 
notification rates observed in young HIV positive females compared to HIV positive males in 
this population. This also suggests that young females in this population are not 
experiencing socio-cultural barriers accessing services relative to males. This contrasts with 
other countries such as Bangladesh where consistently higher TB notification rates among 
males is commonly attributed to females' lack of access and under notification of TB [10, 11, 
17, 18]. Furthermore, as previously mentioned, HIV positive individuals are more likely to 
have extra-pulmonary TB and less TB bacilli present [27], which is difficult to diagnose and 
may lead to under diagnosis. Therefore, these notification rates may only be the tip of the 
iceberg of an even higher incidence of TB among young females that remains undetected. 
 
While HIV has a significant effect on TB-related gender differences, controlling for HIV does 
not nullify epidemiological differences of TB disease in males and females in this population. 
This indicates that there are additional underlying biological and lifestyle risk factors 
differentially affecting males and females. For example, males are more likely than females 
to smoke cigarettes and drink alcohol [37] as well as have genetic polymorphisms [12],  
which may increase their risk of developing TB disease. Females, on the otherhand, are 
more likely than males to be obese, have diabetes, or be exposed to domestic fuels [37], 
which may also explain their increased risk of developing TB disease. These risk factors 
may also contribute to the observed TB-related gender differences in this population. 
 
There were some limitations to this study. We were confined to the data recorded in the 
electronic TB register, which had some missing data and inconsistencies, although rigorous 
data cleaning was employed to avoid introducing information bias. In addition, we were 
unable to investigate un-notified TB cases or explore associations between gender and other 
known risk factors for TB such as socio-economic status, living conditions, and substance 
abuse. The apportioning of HIV unknown TB cases as probable HIV positive and HIV 
negative was an estimate; however, the sensitivity analysis concluded that all three 
scenarios yielded similar results, which indicates that these estimates are robust. In addition, 
while the Cape Town population denominators were also estimates, they were derived from 
the ASSA model, which is accepted as the most valid source of population estimates for 
South Africa. The caveat, though, is that the ASSA model lacks reliable HIV positive 
denominators for adolescents. However, this was addressed with the Poisson regression 
model, which estimated more accurate rates for adolescents that were consistent with the 
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6.1 Recommendations 
 
It is important to improve HIV and TB testing and treatment rates for females, particularly 
young females who are most vulnerable to both infections. Females who test smear-
negative should be highly encouraged to test for HIV. Those who test HIV positive and are 
eligible for ART should start ART immediately to reduce the risk of developing TB or 
suffering TB-related complications. Conversely, HIV positive females require early diagnosis 
and treatment to decrease the likelihood of serious TB-related complications. Clinicians need 
to have a higher index of suspicion of TB in young females and pay closer attention to signs 
and symptoms of extra-pulmonary TB. Although diagnosing extra-pulmonary TB is difficult, 
initial TB symptom screening as well as non-invasive clinical exams to detect extra-
pulmonary TB through palpating lymph nodes or utilizing the point-of-care 
Lipoarabinomannan (LAM) urine dipstick could be done at schools, followed by further 
investigation. However, given the high prevalence of HIV among young females in this 
population, which often leads to smear-negative TB, it is likely that they are less infectious 
and therefore not the primary transmitters of TB infection in this populatio .  
 
In this population, older males are more likely than females to be HIV negative and have 
smear-positive, pulmonary TB, rendering them more infectious. They are therefore more 
likely to be the primary drivers of the TB epidemic in this population. While the HIV epidemic 
has significantly affected females’ susceptibility to TB, it most likely has not had such an 
effect in HIV negative individuals, particularly males. To curb TB disease in males, more 
aggressive symptom screening and rapid diagnosis for smear-positive TB using 
technologies such as GeneXpert should be considered in the workplace and communities to 
target older, HIV negative males.  
 
In addition to clinical interventions, upstream educational programmes are a necessary 
component of TB prevention and control strategies. Particularly for young females, it is 
important to strengthen HIV prevention strategies such as improved sexual and reproductive 
health services, TB/HIV integration and life skills courses to enhance decision-making, 
power, and communication skills. These programmes should also focus on reducing 
transactional or cross-generational sexual relationships, a common occurrence in this 
population, which may also be putting young females at risk of developing not only HIV but 
also TB [40, 41]. For older males, it is also important to strengthen education about TB 
symptoms, transmission, and risk factors for transmission. 
 
Further research should consider investigating additional underlying risk factors for gender 
differences in TB such as lifestyle, epidemiological, socio-cultural, and biological pathways. 
In addition, further epidemiological research to identify risk factors for TB transmission in 
younger females and older males, including transactional sex and "hotspot" locations for TB 
transmission, such as transportation and schools, should be undertaken. In order to 
strengthen research methodology, researchers along with public health officials should also 
acquire more accurate population denominators to measure TB incidence rates, particularly 
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7.0 CONCLUSIONS 
In conclusion, there are significant gender differences related to TB in this population and
HIV is a major contributing factor affecting these differences, especially among young 
females. HIV/TB co-infection increases pre-existing clinical differences between male and 
female TB cases. In the presence of HIV infection, even fewer females than males have
smear results recorded and among those with recorded results, they are less likely than
males to be diagnosed as smear-positive or have severe smear positivity grading. In
addition, similar age and gender distributions of TB notification rates have been reported
only in Uganda, Malawi and during the mid-20th century. Among HIV co-infected individuals,
young females had a higher TB notification rate than young males and there were decreased 
differences between male and female rates overall as compared to HIV negative individuals. 
However, even when HIV is controlled for, gender differences persist, which indicates that 
there are additional underlying biological and lifestyle risk factors for gender differences in
TB that require further investigation. These findings warrant the need to implement a multi-
pronged approach to TB control which focuses on young females and older males and 
includes integrated, rapid HIV testing and TB screening, educational programmes, and
behaviour-change interventions.   
8.0 LIST OF ABBREVIATIONS 
ASSA Actuarial Society of South Africa 
CI Confidence Interval 
DOTS Directly Observed Therapy, Short-course 
HIV Human Immunodeficiency Virus 
IQR Interquartile range 
NRR Notification rate ratio
OR Odds ratio 
TB Tuberculosis 
9.0 COMPETING INTERESTS 
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1.2 City Health, City of Cape Town 
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2.1 Table 1 - 2009 Cape Town tuberculosis cases by age, gender and HIV (0 - ≥75 years old) 
Age 
(years) 
HIV positive TB cases HIV negative TB cases HIV unknown TB cases 
Total Female Male 
Standardized 
F:M ratio* 
Total Female Male 
Standardized 
F:M ratio* 
Total Females Males 
Standardized 
F:M ratio* 
0-4 313 170 143 1.03 1,582 777 805 1.55 958 450 508 1.34 
5-9 133 62 71 0.76 372 184 188 1.57 217 97 120 1.22 
10-14 75 44 31 1.23 227 135 92 2.36 91 51 40 1.92 
15-19 197 172 25 5.96 988 485 503 1.55 251 130 121 1.62 
20-24 1,098 877 221 3.44 1,693 711 982 1.16 393 167 226 1.12 
25-29 2,538 1,697 841 1.75 1,380 489 891 0.88 376 155 221 1.06 
30-34 2,974 1,582 1,392 0.99 1,015 328 687 0.77 295 93 202 0.69 
35-39 2,452 1,054 1,398 0.65 1,042 311 731 0.68 268 76 192 0.60 
40-44 1,584 685 899 0.66 1,053 351 702 0.80 203 70 133 0.79 
45-49 954 378 576 0.57 1,076 343 733 0.75 215 54 161 0.51 
50-54 493 202 291 0.60 829 239 590 0.65 157 48 109 0.66 
55-59 269 107 162 0.57 571 173 398 0.70 123 30 93 0.49 
60-64 105 39 66 0.51 315 108 207 0.84 73 21 52 0.61 
65-69 34 16 18 0.77 195 79 116 1.09 50 14 36 0.59 
70-74 11 3 8 0.33 72 42 30 2.25 24 12 12 1.51 
≥75 7 3 4 0.65 97 45 52 1.39 40 20 20 1.51 
Total 13,237 7,091 6,146 1.00 12,507 4,800 7,707 1.00 3,734 1,488 2,246 1.00 
*Standardized female:male ratios were determined by dividing age-specific female:male ratios by the overall crude female:male ratio of 1.15, 0.62 and 0.66 among 
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2.2 Table 2 - Estimated 2009 mid-year Cape Town population by age, gender and HIV (0-≥75 years old)  
Age 
(years) 
Total population HIV positive sub-population HIV negative sub-population 
Total Female Male Standardized 
F:M ratio* 
Total Female Male Standardized 
F:M ratio* 
Total Female Male Standardized 
F:M ratio* 
0-4 316,078 156,309 159,769 0.97 6,630 3,286 3,344 0.63 309,448 153,023 156,425 1.00 
5-9 322,819 159,618 163,201 0.97 3,493 1,731 1,762 0.63 319,326 157,887 161,439 1.00 
10-14 312,137 154,837 157,300 0.98 430 215 216 0.63 311,707 154,622 157,084 1.00 
15-19 304,903 153,305 151,598 1.00 3,456 3,348 109 19.64 301,447 149,957 151,489 1.01 
20-24 327,113 163,577 163,536 0.99 20,903 17,397 3,506 3.16 306,210 146,180 160,030 0.93 
25-29 330,742 160,541 170,201 0.94 43,582 29,232 14,350 1.30 287,160 131,309 155,851 0.86 
30-34 298,919 142,233 156,686 0.90 47,194 27,455 19,739 0.89 251,725 114,778 136,947 0.85 
35-39 257,267 126,089 131,178 0.95 33,229 18,704 14,525 0.82 224,038 107,385 116,653 0.94 
40-44 197,947 100,073 97,874 1.01 18,423 10,331 8,093 0.81 179,524 89,742 89,781 1.02 
45-49 183,414 95,804 87,610 1.08 12,019 6,452 5,568 0.74 171,395 89,352 82,042 1.11 
50-54 163,071 86,690 76,381 1.13 6,833 3,135 3,698 0.54 156,238 83,555 72,683 1.17 
55-59 130,157 69,752 60,405 1.15 3,419 1,250 2,169 0.37 126,738 68,502 58,236 1.20 
60-64 106,269 56,599 49,670 1.13 1,551 479 1,072 0.28 104,718 56,120 48,598 1.18 
65-69 77,547 40,919 36,628 1.11 316 77 240 0.20 77,231 40,842 36,388 1.14 
70-74 52,142 27,233 24,909 1.08 22 4 19 0.13 52,120 27,229 24,890 1.11 
≥75 62,485 35,135 27,350 1.27 0.23 0.03 0.19 0.11 62,485 35,135 27,350 1.31 
Total 3,443,010 1,728,714 1,714,296 1.00 201,502 123,094 78,408 1.00 3,241,508 1,605,620 1,635,888 1.00 
*Standardized female:male ratios were determined by dividing age-specific female:male ratios by the overall crude female:male ratio of 1.01, 1.57 and 0.98 among 














Gender and tuberculosis | Appendices 7 
2.3 Table 3 - Sensitivity analysis of notification rate ratios for apportioning HIV unknown tuberculosis cases as probable HIV positive 
and HIV negative (15-54 years old) 
Age (years) 













15-19 0.22 1.00 0.22 1.00 0.16 0.95 
20-24 0.80 0.80 0.80 0.80 0.73 0.74 
25-29 0.99 0.69 0.99 0.69 0.94 0.62 
30-34 0.82 0.57 0.82 0.57 0.77 0.54 
35-39 0.59 0.46 0.59 0.46 0.54 0.45 
40-44 0.60 0.50 0.60 0.50 0.56 0.49 
45-49 0.57 0.41 0.57 0.41 0.51 0.41 
50-54 0.82 0.36 0.82 0.36 0.79 0.35 
*HIV unknown tuberculosis cases apportioned as HIV positive cases; 
†
HIV unknown cases apportioned as HIV negative cases; 
‡
HIV unknown cases apportioned
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2.4 Table 4 - Estimated* 2009 Cape Town tuberculosis notification rates (per 100,000) by age, gender, and HIV (15-54 years old) 
Age (years) 







15-19 7,380 6,568 1.12 372 427 0.87 
20-24 6,123 6,972 0.88 515 757 0.68 
25-29 6,495 7,346 0.88 429 625 0.69 
30-34 6,367 8,476 0.75 315 541 0.58 
35-39 6,387 11,640 0.55 296 697 0.43 
40-44 7,827 13,397 0.58 397 877 0.45 
45-49 6,785 13,063 0.52 410 1,018 0.40 
50-54 6,161 11,025 0.56 372 859 0.43 
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Assistance with the process of manuscript preparation and submission is available from BioMed Central customer support team. 
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tools and resources for scientific authors on our page. 
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Authors' contributions 
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be 
specified in this section. 
An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study. To 
qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis 
and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; 
and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take 
public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the 
research group, alone, does not justify authorship. 
We suggest the following kind of format (please use initials to refer to each author's contribution): AB carried out the molecular 
genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT 
participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG 
conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and 
approved the final manuscript. 
All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who 
might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided 
only general support. 
Authors' information 
You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of 
the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current 
positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their 
initials. Note this section should not be used to describe any competing interests. 
Acknowledgements 
Please acknowledge anyone who contributed towards the article by making substantial contributions to conception, design, 
acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for 
important intellectual content, but who does not meet the criteria for authorship. Please also include the source(s) of funding for 
each author, and for the manuscript preparation. Authors must describe the role of the funding body, if any, in design, in the 
collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for 
publication. Please also acknowledge anyone who contributed materials essential for the study. If a language editor has made 
significant revision of the manuscript, we recommend that you acknowledge the editor by name, where possible. 
The role of a scientific (medical) writer must be included in the acknowledgements section, including their source(s) of funding. We 
suggest wording such as 'We thank Jane Doe who provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.' 
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section. 
Endnotes 
Endnotes should be designated within the text using a superscript lowercase letter and all notes (along with their corresponding 
letter) should be included in the Endnotes section. Please format this section in a paragraph rather than a list. 
References 
All references, including URLs, must be numbered consecutively, in square brackets, in the order in which they are cited in the text, 
followed by any in tables or legends. Each reference must have an individual reference number. Please avoid excessive 
referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully 
formatted before submission. 
Only articles, datasets and abstracts that have been published or are in press, or are available through public e-print/preprint 
servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the 
reference list, but may be included in the text and referred to as "unpublished observations" or "personal communications" giving the 
names of the involved researchers. Obtaining permission to quote personal communications and unpublished data from the cited 
colleagues is the responsibility of the author. Footnotes are not allowed, but endnotes are permitted. Journal abbreviations follow 
Index Medicus/MEDLINE. Citations in the reference list should include all named authors, up to the first 30 before adding 'et al.'. 
Any in press articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made 
available if requested by the editorial office. 
Style files are available for use with popular bibliographic management software: 
 BibTeX 
 EndNote style file 
 Reference Manager 
 Zotero 
Examples of the BMC Infectious Diseases reference style are shown below. Please ensure that the reference style is followed 
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All web links and URLs, including links to the authors' own websites, should be given a reference number and included in the 
reference list rather than within the text of the manuscript. They should be provided in full, including both the title of the site and the 
URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do]. If an author or 
group of authors can clearly be associated with a web link, such as for weblogs, then they should be included in the reference. 
Examples of the BMC Infectious Diseases reference style 
Article within a journal 
Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat Genet 1996,13:266-267. 
Article within a journal supplement 
Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, 
secondary structure, and contacts prediction. Proteins 1999,43(Suppl 3):149-170. 
In press article 
Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press. 
Published abstract 
Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, stromal derived factor-1 and 
rheumatoid arthritis [abstract]. Arthritis Rheum 1999, 42:s250. 
Article within conference proceedings 
Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 
1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27. 
Book chapter, or article within a book
Schnepf E: From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Origins of Plastids. Volume
2. 2nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76.
Whole issue of journal
Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72.
Whole conference proceedings 
Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-
Heinemann; 1996. 
Complete book 
Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970. 
Monograph or book in a series
Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues.Edited by Harris TJR. New York:
Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vol 1.]
Book with institutional author
Advisory Committee on Genetic Modification: Annual Report. London; 1999.
PhD thesis 
Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. Stanford University, Computer 
Science Department; 1995. 
Link / URL 
The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do] 
Link / URL with author(s)
Corpas M: The Crowdfunding Genome Project: a personal genomics community with open source values
[http://blogs.biomedcentral.com/bmcblog/2012/07/16/the-crowdfunding-genome-project-a-personal-genomics-community-with-open-
source-values/]
Dataset with persistent identifier 
Zheng, L-Y; Guo, X-S; He, B; Sun, L-J; Peng, Y; Dong, S-S; Liu, T-F; Jiang, S; Ramachandran, S; Liu, C-M; Jing, H-C 
(2011): Genome data from sweet and grain sorghum (Sorghum bicolor).GigaScience. http://dx.doi.org/10.5524/100012. 
Clinical trial registration record with persistent identifier 
Mendelow, AD (2006): Surgical Trial in Lobar Intracerebral Haemorrhage. Current Controlled 
Trials. http://dx.doi.org/10.1186/ISRCTN22153967 
Preparing illustrations and figures 
Illustrations should be provided as separate files, not embedded in the text file. Each figure should include a single illustration and 
should fit on a single page in portrait format. If a figure consists of separate parts, it is important that a single composite illustration 
file be submitted which contains all parts of the figure. There is no charge for the use of color figures. 
Please read our figure preparation guidelines for detailed instructions on maximising the quality of your figures. 
Formats 
The following file formats can be accepted: 
 PDF (preferred format for diagrams)
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 PPTX/PPT (single slide only) 
 EPS 





The legends should be included in the main manuscript text file at the end of the document, rather than being a part of the figure file. 
For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 
3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words. 
Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables 
that have previously been published elsewhere. 
Preparing tables 
Each table should be numbered and cited in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title 
(above the table) that summarizes the whole table; it should be no longer than 15 words. Detailed legends may then follow, but they 
should be concise. Tables should always be cited in text in consecutive numerical order. 
Smaller tables considered to be integral to the manuscript can be pasted into the end of the document text file, in A4 portrait or 
landscape format. These will be typeset and displayed in the final published form of the article. Such tables should be formatted 
using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent 
electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Columns 
and rows of data should be made visibly distinct by ensuring that the borders of each cell display as black lines. Commas should not 
be used to indicate numerical values. Color and shading may not be used; parts of the table can be highlighted using symbols or 
bold text, the meaning of which should be explained in a table legend. Tables should not be embedded as figures or spreadsheet 
files. 
Larger datasets or tables too wide for a portrait page can be uploaded separately as additional files. Additional files will not be 
displayed in the final, laid-out PDF of the article, but a link will be provided to the files as supplied by the author. 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or comma separated values (.csv). As with 
all files, please use the standard file extensions. 
Preparing additional files 
Although BMC Infectious Diseases does not restrict the length and quantity of data included in an article, we encourage authors to 
provide datasets, tables, movies, or other information as additional files. 
Please note: All Additional files will be published along with the article. Do not include files such as patient consent forms, 
certificates of language editing, or revised versions of the main manuscript document with tracked changes. Such files should be 
sent by email to editorial@biomedcentral.com, quoting the Manuscript ID number. 
Results that would otherwise be indicated as "data not shown" can and should be included as additional files. Since many weblinks 
and URLs rapidly become broken, BMC Infectious Diseasesrequires that supporting data are included as additional files, or 
deposited in a recognized repository. Please do not link to data on a personal/departmental website. The maximum file size for 
additional files is 20 MB each, and files will be virus-scanned on submission. 
Additional files can be in any format, and will be downloadable from the final published article as supplied by the author. We 
encourage authors to use formats which facilitate reuse. e.g. We recommend CSV rather than PDF for tabular data. 
Certain supported files formats are recognized and can be displayed to the user in the browser. These include most movie formats 
(for users with the Quicktime plugin), mini-websites prepared according to our guidelines, chemical structure files (MOL, PDB), 
geographic data files (KML). 
If additional material is provided, please list the following information in a separate section of the manuscript text: 
 File name (e.g. Additional file 1) 
 File format including the correct file extension for example .pdf, .xls, .txt, .pptx (including name and a URL of an 
appropriate viewer if format is unusual) 
 Title of data 
 Description of data 
Additional files should be named "Additional file 1" and so on and should be referenced explicitly by file name within the body of the 
article, e.g. 'An additional movie file shows this in more detail [see Additional file 1]'. 
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Ideally, file formats for additional files should not be platform-specific, and should be viewable using free or widely available tools. 
The following are examples of suitable formats. 
 Additional documentation
o PDF (Adode Acrobat)
 Animations
o SWF (Shockwave Flash)
 Movies
o MP4 (MPEG 4)
o MOV (Quicktime)
 Tabular data
o XLS, XLSX (Excel Spreadsheet)
o CSV (Comma separated values)
As with figure files, files should be given the standard file extensions. 
Mini-websites 
Small self-contained websites can be submitted as additional files, in such a way that they will be browsable from within the full text
HTML version of the article. In order to do this, please follow these instructions:
1. Create a folder containing a starting file called index.html (or index.htm) in the root.
2. Put all files necessary for viewing the mini-website within the folder, or sub-folders.
3. Ensure that all links are relative (ie "images/picture.jpg" rather than "/images/picture.jpg" or 
"http://yourdomain.net/images/picture.jpg" or "C:\Documents and Settings\username\My Documents\mini-
website\images\picture.jpg") and no link is longer than 255 characters.
4. Access the index.html file and browse around the mini-website, to ensure that the most commonly used browsers
(Internet Explorer and Firefox) are able to view all parts of the mini-website without problems, it is ideal to check this on a
different machine.
5. Compress the folder into a ZIP, check the file size is under 20 MB, ensure that index.html is in the root of the ZIP, and that
the file has .zip extension, then submit as an additional file with your article.
Style and language 
General 
Currently, BMC Infectious Diseases can only accept manuscripts written in English. Spelling should be US English or British
English, but not a mixture.
There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is also no restriction on
the number of figures, tables or additional files that can be included with each article online. Figures and tables should be numbered
in the order in which they are referred to in the text. Authors should include all relevant supporting data with each article.
BMC Infectious Diseases will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if
it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by 
colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a
copyediting service.
Language editing 
For authors who wish to have the language in their manuscript edited by a native-English speaker with scientific expertise, BioMed 
Central recommends Edanz. BioMed Central has arranged a 10% discount to the fee charged to BioMed Central authors by Edanz. 
Use of an editing service is neither a requirement nor a guarantee of acceptance for publication. Please contact Edanz directly to 
make arrangements for editing, and for pricing and payment details. 
Help and advice on scientific writing 
The abstract is one of the most important parts of a manuscript. For guidance, please visit our page on Writing titles and abstracts 
for scientific articles. 
Tim Albert has produced for BioMed Central a list of tips for writing a scientific manuscript. American Scientist also provides a list of 
resources for science writing. For more detailed guidance on preparing a manuscript and writing in English, please visit the BioMed 
Central author academy. 
Abbreviations 
Abbreviations should be used as sparingly as possible. They should be defined when first used and a list of abbreviations can be 
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 Please use double line spacing.
 Type the text unjustified, without hyphenating words at line breaks.
 Use hard returns only to end headings and paragraphs, not to rearrange lines.
 Capitalize only the first word, and proper nouns, in the title.
 All pages should be numbered.
 Use the BMC Infectious Diseases reference format.
 Footnotes are not allowed, but endnotes are permitted.
 Please do not format the text in multiple columns.
 Greek and other special characters may be included. If you are unable to reproduce a particular special character, please
type out the name of the symbol in full. Please ensure that all special characters used are embedded in the text, otherwise
they will be lost during conversion to PDF.
Units 
SI units should be used throughout (liter and molar are permitted, however). 
